511 related articles for article (PubMed ID: 16641878)
1. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
2. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
3. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
4. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy].
Werle E; Bostedt A; Fiehn W; Hasslacher C
Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487
[TBL] [Abstract][Full Text] [Related]
5. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of cathepsin B and cystatins as parameters of tubular damage.
Schaefer L; Gilge U; Heidland A; Schaefer RM
Kidney Int Suppl; 1994 Nov; 47():S64-7. PubMed ID: 7869675
[TBL] [Abstract][Full Text] [Related]
7. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
10. Urinary PC-1 activity in patients with type 1 diabetes mellitus.
Stefanović V; Rajić M; Antić S; Mitić-Zlatković M; Stojiljković S; Ivić MA; Vlahović P
Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834
[TBL] [Abstract][Full Text] [Related]
11. Tubular dysfunction in the early stage of diabetic nephropathy.
Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
[TBL] [Abstract][Full Text] [Related]
12. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions].
Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV
Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303
[TBL] [Abstract][Full Text] [Related]
13. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C
Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
[TBL] [Abstract][Full Text] [Related]
16. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
17. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
18. [Urinary proteins in patients with diabetes mellitus].
Hofmann W; Guder WG
Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508
[TBL] [Abstract][Full Text] [Related]
19. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
[TBL] [Abstract][Full Text] [Related]
20. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]